S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut

Benitec Biopharma (BNTC) Institutional Ownership

$6.82
+2.02 (+42.08%)
(As of 04/18/2024 ET)

Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)

Current
Institutional Ownership
Percentage
52.19%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$679.56K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$537.57K
Get BNTC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BNTC Institutional Buying and Selling by Quarter

Benitec Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.16,701$54K0.0%N/A0.645%
2/15/2024Vanguard Group Inc.16,701$54K0.0%N/A0.655%
11/15/2023Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419%
5/12/2023Renaissance Technologies LLC224,879$47K0.0%-40.1%0.804%
2/15/2023Morgan Stanley368,923$63K0.0%+385.5%1.318%
2/13/2023Renaissance Technologies LLC375,531$64K0.0%+211.8%1.342%
11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848%
11/15/2022Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478%
11/14/2022Armistice Capital LLC1,555,039$578K0.0%N/A6.025%
11/14/2022Renaissance Technologies LLC120,429$45K0.0%N/A0.467%
11/14/2022Altium Capital Management LP658,796$245K0.1%N/A2.552%
8/15/2022Millennium Management LLC25,132$29K0.0%N/A0.308%
8/13/2022Virtu Financial LLC47,393$55K0.0%N/A0.580%
5/13/2022Silverarc Capital Management LLC492,880$57K0.0%-16.1%6.031%
11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244%
8/16/2021State Street Corp21,000$89K0.0%N/A0.267%
8/13/2021Renaissance Technologies LLC42,700$181K0.0%N/A0.544%
8/13/2021Northern Trust Corp11,813$50K0.0%N/A0.150%
8/13/2021Geode Capital Management LLC34,493$146K0.0%+20.8%0.439%
8/13/2021Vanguard Group Inc.74,773$318K0.0%+43.3%0.952%
8/11/2021Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190%
7/31/2021Private Wealth Advisors LLC15,043$64K0.0%N/A0.192%
5/21/2021Citadel Advisors LLC23,253$120K0.0%N/A0.483%
5/19/2021Virtu Financial LLC22,520$116K0.0%+17.8%0.467%
5/18/2021Citadel Advisors LLC23,253$120K0.0%N/A0.483%
5/13/2021Bank of New York Mellon Corp17,653$91K0.0%N/A0.366%
5/12/2021Geode Capital Management LLC28,560$147K0.0%N/A0.593%
4/14/2021WealthTrust Axiom LLC12,950$66K0.0%N/A0.269%
4/12/2021HighPoint Advisor Group LLC93,000$462K0.1%N/A1.930%
3/4/2021Hudson Bay Capital Management LP107,995$324K0.0%N/A2.241%
2/24/2021Virtu Financial LLC19,114$57K0.0%N/A0.397%
2/16/2021Warberg Asset Management LLC10,000$30K0.0%N/A0.903%
2/10/2021Renaissance Technologies LLC50,660$152K0.0%N/A4.572%
11/13/2020Morgan Stanley34,838$219K0.0%+18.7%3.144%
8/14/2020Sabby Management LLC11,863$94K0.0%-45.1%1.108%
5/15/2020Sabby Management LLC21,592$85K0.0%-81.7%2.016%
5/15/2020Morgan Stanley28,690$113K0.0%+82.1%2.679%
(Data available from 1/1/2016 forward)

BNTC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BNTC shares?

During the previous two years, 11 institutional investors and hedge funds held shares of Benitec Biopharma. The most heavily invested institutionals were Armistice Capital LLC ($578K), Adage Capital Partners GP L.L.C. ($572K), Empery Asset Management LP ($296K), Altium Capital Management LP ($245K), Morgan Stanley ($63K), Silverarc Capital Management LLC ($57K), and Virtu Financial LLC ($55K).Learn more on BNTC's institutional investors.

What percentage of Benitec Biopharma stock is owned by institutional investors?

52.19% of Benitec Biopharma stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings.

Which institutional investors have been buying Benitec Biopharma stock?

Of the 10 institutional investors that purchased Benitec Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.56M), Empery Asset Management LP ($796.84K), Altium Capital Management LP ($658.80K), Renaissance Technologies LLC ($375.53K), Morgan Stanley ($292.93K), Adage Capital Partners GP L.L.C. ($189.19K), and Cantor Fitzgerald L. P. ($133.81K).

How much institutional buying is happening at Benitec Biopharma?

Institutional investors have bought a total of 4,108,052 shares in the last 24 months. This purchase volume represents approximately $24.32M in transactions.

Which Benitec Biopharma major shareholders have been selling company stock?

The following institutional investors have sold Benitec Biopharma stock in the last 24 months: Renaissance Technologies LLC ($150.65K), and Silverarc Capital Management LLC ($94.62K).

How much institutional selling is happening at Benitec Biopharma?

Institutional investors have sold a total of 245,271 shares in the last 24 months. This volume of shares sold represents approximately $4.29M in transactions.


This page (NASDAQ:BNTC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners